These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21727769)

  • 61. The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Treansplantation.
    Gratwohl A
    Int J Hematol; 2002 Aug; 76 Suppl 1():386-92. PubMed ID: 12430888
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).
    Parikh S; Szabolcs P
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S53-5. PubMed ID: 22226113
    [No Abstract]   [Full Text] [Related]  

  • 63. Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).
    Aljurf M; Zaidi SZ; Hussain F; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mahmoud HK; Haddad A; Adil S; Ben Othman T; Sarhan MM; Dennison D; Ibrahim A; Benchekroun S; Ayas M; Al Zahrani H; Al Mohareb F; El Solh H
    Transfus Apher Sci; 2010 Apr; 42(2):169-75. PubMed ID: 20110194
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia.
    Dominietto A; Vagge S; di Grazia C; Bregante S; Raiola AM; Varaldo R; Gualandi F; Gusinu M; Barra S; Agostinelli S; Angelucci E; Hui S
    Transplant Cell Ther; 2023 Aug; 29(8):506.e1-506.e6. PubMed ID: 37094701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: current options and future potential.
    Hwang WY; Ong SY
    Ann Acad Med Singap; 2009 Apr; 38(4):340-6. PubMed ID: 19434337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Durable Cord Blood Cell Engraftment in a Patient with Severe Aplastic Anemia after a Matched Sibling Bone Marrow Transplantation and an Unrelated Cord Blood Transplantation.
    Wei ZL; Huang LQ; Jiang YZ; Yan JW; Wang NN; Huang DP
    Ann Clin Lab Sci; 2021 Sep; 51(5):726-729. PubMed ID: 34686517
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hematopoietic cell transplantation for nonmalignant disorders.
    Tolar J; Mehta PA; Walters MC
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S166-71. PubMed ID: 22226101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
    Zhang XH; Chen J; Han MZ; Huang H; Jiang EL; Jiang M; Lai YR; Liu DH; Liu QF; Liu T; Ren HY; Song YP; Sun ZM; Tang XW; Wang JM; Wu DP; Xu LP; Zhang X; Zhou DB; Huang XJ
    J Hematol Oncol; 2021 Sep; 14(1):145. PubMed ID: 34526099
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Graft-
    Devillier R; Eikema DJ; Dufour C; Aljurf M; Wu D; Maschan A; Kulagin A; Halkes CJM; Collin M; Snowden J; Renard C; Ganser A; Sykora KW; Gibson BE; Maertens J; Itäla-Remes M; Corti P; Cornelissen J; Bornhäuser M; Araujo MC; Ozdogu H; Risitano A; Socie G; De Latour RP
    Haematologica; 2023 Sep; 108(9):2305-2315. PubMed ID: 36951165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.
    Aljurf MD; Zaidi SZ; El Solh H; Hussain F; Ghavamzadeh A; Mahmoud HK; Shamsi T; Othman TB; Sarhan MM; Dennison D; Ibrahim A; Benchekroun S; Chaudhri N; Labar B; Horowitz M; Niederwieser D; Gratwohl A
    Bone Marrow Transplant; 2009 Jan; 43(1):1-12. PubMed ID: 19043456
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.
    Çiftçiler R; Göker H; Demiroğlu H; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe O; Tekin F; Büyükaşık Y
    Turk J Haematol; 2019 May; 36(2):88-96. PubMed ID: 30717586
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.
    Passweg JR; Baldomero H; Bargetzi M; Bucher C; Chalandon Y; Duchosal MA; Gratwohl A; Güngör T; Hess U; Leibundgut K; de Faveri GN; Ozsahin H; Pabst T; Renner C; Stern M; Stussi G; Schanz U;
    Swiss Med Wkly; 2013; 143():w13757. PubMed ID: 23443995
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
    Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
    Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.